BAY-2327949

N/A

Report date: 2022/12/29 12:33:20
NME

Base Information

Drug NameBAY-2327949
Drug Alias NameBAY-2327949
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVasopressin V1a receptor agonists
TargetsVasopressin V1a receptor
Therapy Area/IndicationsRenal Insufficiency, ChronicNephrosisDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenNetherlandsNorway +[9] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer AG
Inactive CompaniesN/A
Active IndicationsRenal Insufficiency, Chronic
Inactive IndicationsNephrosisDiabetic Nephropathies

Other Information

ATC CodeN/A
Related LinksN/A